A Study to Evaluate the Cardiac Safety of a Single Dose of AL-335 Administered on a Background of Simeprevir and Odalasvir and of Repeated Doses of Odalasvir Administered Alone in Healthy Participants
Clinical trial NCT03155893 · COMPLETED
Trial details
- NCT number
- NCT03155893
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-12
- Primary completion
- 2017-10-27
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.